Compile Data Set for Download or QSAR
Report error Found 197 Enz. Inhib. hit(s) with all data for entry = 11798
TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648786(US20240034729, Compound 178)
Affinity DataIC50: 0.100nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648788(US20240034729, Compound 180)
Affinity DataIC50: 0.200nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648787(US20240034729, Compound 179)
Affinity DataIC50: 0.400nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648780(US20240034729, Compound 172)
Affinity DataIC50: 0.700nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648785(US20240034729, Compound 177)
Affinity DataIC50: 1.10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648782(US20240034729, Compound 174)
Affinity DataIC50: 1.60nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648781(US20240034729, Compound 173)
Affinity DataIC50: 1.80nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648789(US20240034729, Compound 181)
Affinity DataIC50: 1.80nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648779(US20240034729, Compound 171)
Affinity DataIC50: 2.10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648790(US20240034729, Compound 182)
Affinity DataIC50: 3.5nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648791(US20240034729, Compound 183)
Affinity DataIC50: 5.5nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648792(US20240034729, Compound 184)
Affinity DataIC50: 5.60nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648784(US20240034729, Compound 176)
Affinity DataIC50: 7.5nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648796(US20240034729, Compound 188)
Affinity DataIC50: 9nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648656(US20240034729, Compound 49)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648649(US20240034729, Compound 42)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648775(US20240034729, Compound 167)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648650(US20240034729, Compound 43)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648651(US20240034729, Compound 44)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648777(US20240034729, Compound 169)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648661(US20240034729, Compound 54)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648662(US20240034729, Compound 55)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648663(US20240034729, Compound 56)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648664(US20240034729, Compound 57)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648657(US20240034729, Compound 50)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648659(US20240034729, Compound 52)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648660(US20240034729, Compound 53)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648763(US20240034729, Compound 155)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648764(US20240034729, Compound 156)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648765(US20240034729, Compound 157)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648766(US20240034729, Compound 158)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648759(US20240034729, Compound 151)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648634(US20240034729, Compound 27)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648760(US20240034729, Compound 152)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648636(US20240034729, Compound 29)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648762(US20240034729, Compound 154)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648645(US20240034729, Compound 38)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648771(US20240034729, Compound 163)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648773(US20240034729, Compound 165)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648774(US20240034729, Compound 166)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648641(US20240034729, Compound 34)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648767(US20240034729, Compound 159)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648768(US20240034729, Compound 160)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648644(US20240034729, Compound 37)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648770(US20240034729, Compound 162)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648688(US20240034729, Compound 81)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648684(US20240034729, Compound 77)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648797(US20240034729, Compound 189)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648798(US20240034729, Compound 190)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetP2X purinoceptor 3(Human)
Wuhan Ll Science and Technology Development

US Patent
LigandPNGBDBM648665(US20240034729, Compound 58)
Affinity DataIC50: 10nMAssay Description:The antagonist property of the compounds disclosed herein was determined using the FLIPR (fluorescence imaging plate reader) method, showing that the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

Displayed 1 to 50 (of 197 total ) | Next | Last >>
Jump to: